Company intelligence / Profile preview

Tulip Diagnostics

Ownership: Private
Development stage: Other

Overview

Tulip Diagnostics manufactures and markets a broad portfolio of in-vitro diagnostic reagents and kits for clinical laboratories. Its products are widely used in India and exported to over eighty countries. The company holds ISO certifications; some products are CE marked or WHO prequalified. No clinical trial results as it does not develop therapeutics.

Therapeutic areas: Metabolic DisordersPsychiatryInfectious DiseasesHematologyCardiovascularOncologyRheumatologyWomen's Health
Modalities: DeviceDiagnostic kit (In-vitro diagnostic reagents and kits)Rapid test kit (e.g., lateral flow assays)ELISA-based diagnosticsChemiluminescence-based diagnosticsSmall molecule detection kitsAntibody-based detection kits
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Tulip Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tulip Diagnostics.

Explore the full profile